版本:
中国

BRIEF-Neurocrine Biosciences prices $450 mln convertible senior notes offering

April 26 Neurocrine Biosciences Inc

* Prices $450.0 million convertible senior notes offering

* Priced offering of $450.0 million aggregate principal amount of 2.25% convertible senior notes due 2024 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐